Deflazacort 6 Mg

Price 2 INR/ Box

Get a Price/Quote

MOQ : 100 Boxes

Deflazacort 6 Mg Specification

Salt Composition
Deflazacort 6 Mg

Pacakaging (Quantity Per Box)
10x10

Dosage Form
Tablets

Ingredients
Deflazacort 6 mg tablets are a corticosteroid medication primarily used to treat Duchenne muscular dystrophy (DMD), and a wide range of inflammatory conditions and autoimmune disorders.

Physical Form
Tablets

Dosage
Tablets

Quantity
100 Boxes

Remote Battery Type
AAA

USB Ports
2

Operating System
Android

Refresh Rate
60 Hz

Smart TV Features
Built-in WiFi, Screen Mirroring

Viewing Angle
178

Sleep Timer
Yes

Deflazacort 6 Mg Trade Information

Minimum Order Quantity
100 Boxes

Delivery Time
7 Days

About Deflazacort 6 Mg

Deflazacort 6 mg tablets are a corticosteroid medication primarily used to treat Duchenne muscular dystrophy (DMD), and a wide range of inflammatory conditions and autoimmune disorders.

Primary Use

Duchenne Muscular Dystrophy (DMD): It is indicated for the treatment of DMD in adults and children two years of age and older. Deflazacort helps slow muscle degeneration, preserve muscle strength, improve mobility, and delay complications.

Other Common Uses

As an anti-inflammatory and immunosuppressant agent, deflazacort is also used to manage various other conditions, including:

Inflammatory Conditions: Conditions affecting muscles and joints such as arthritis and ankylosing spondylitis. It also helps manage conditions like asthma, inflammatory bowel disease, and certain eye conditions (uveitis).

Autoimmune Disorders: Conditions where the immune system attacks the body, such as psoriasis, rheumatoid arthritis, eczema, and atopic dermatitis.

Severe Allergies: Provides relief from symptoms of allergic reactions.

Comprehensive Treatment for DMD and Inflammation

Deflazacort 6 mg tablets are specifically developed to support patients diagnosed with Duchenne muscular dystrophy and offer therapeutic relief for a spectrum of inflammatory and autoimmune disorders. By controlling excessive immune reactions and reducing inflammation, these tablets enhance patient quality of life and help manage symptoms effectively.

Convenient Packaging for Bulk Supply

Each shipment includes 100 boxes containing 10x10 tablets per box, facilitating easy distribution, storage, and dispensation for clinics, hospitals, and pharmacies. This bulk quantity ensures that healthcare providers can maintain steady supplies for ongoing patient treatments.

FAQ's of Deflazacort 6 Mg:

Q: How should Deflazacort 6 mg tablets be taken?

A: Deflazacort 6 mg tablets should be taken orally, usually once daily or as directed by a healthcare professional. Dosing may be adjusted based on the patient's medical condition and response to treatment.

Q: What conditions can be managed using Deflazacort 6 mg tablets?

A: These tablets are primarily indicated for Duchenne muscular dystrophy (DMD) and are also used to treat a broad variety of inflammatory and autoimmune disorders, such as certain allergies, arthritis, and respiratory conditions.

Q: When is it appropriate to prescribe Deflazacort 6 mg?

A: Deflazacort 6 mg is typically prescribed when there is a need to control inflammation or modulate the immune system, including during acute flare-ups of DMD or autoimmune diseases as determined by a healthcare professional.

Q: Where can Deflazacort 6 mg be sourced in bulk quantities?

A: Healthcare institutions, pharmacies, and medical suppliers can obtain Deflazacort 6 mg in bulk directly from manufacturers, suppliers, or authorized traders who offer packaging of 100 boxes, each containing 100 tablets.

Q: What is the process for distributing Deflazacort 6 mg tablets to patients?

A: After procurement by healthcare facilities, the tablets are dispensed in appropriate quantities according to pharmacy protocols and the prescribing physician's orders, ensuring patients receive the correct dosage and supply duration.

Q: What are the main benefits of using Deflazacort 6 mg?

A: The primary benefits include effective reduction of inflammation, management of autoimmune responses, and improved symptom control in chronic conditions such as DMD, which can lead to better functional outcomes for patients.

Tell us about your requirement